Gilead Sciences Inc to ramp up production of experimental COVID-19 treatment with international partners

In a statement Gilead Sciences Inc, the maker of the closely-watched experimental coronavirus drug remdesivir stated, it will continue to work with international partners to expand the production of its potential COVID-19 treatment. Gilead said, it expects to have more than one million remdesivir treatment courses manufactured by December, “with plans to be able to…

China’s coronavirus threatens mobile phone industry: Qualcomm’s CFO

The coronavirus outbreak in China poses a potential threat to the mobile phone industry, said Qualcomm Inc while adding that it is likely to impact its manufacturing and sales. These comments by Qualcomm, the world’s biggest supplier of “modem” chips has resulted in the tumbling of chip stocks despite signs that an industry downturn was…